Future in vivo studies using myocardial infarction animal models are therefore essential to confirm whether Quercetin truly exerts cardioprotective effects by modulating VEGFA, PTK2, and GGT1, as predicted in our bioinformatic and molecular docking analyses. The gene discussed is GGT1; the disease is myocardial infarction.